Mariner, LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1373442 Overland Park, KS

Position in AMRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$5,430,579

+$1,508,243 QoQ

Shares Held

313,725

-0.6% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#69

of 308 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Mariner, LLC holds $80,358,857 across 29 Drug Manufacturers - Specialty & Generic names. AMRX ranks #5 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	155,039	$26,130,272
2	UTHR	UNITED THERAPEUTICS Corp	23,965	$12,984,955
3	HLN	Haleon plc	771,516	$7,198,243
4	ZTS	Zoetis Inc.	96,951	$6,966,897
5	AMRX	Amneal Pharmaceuticals, Inc. This page	313,725	$5,430,579
6	TAK	Takeda Pharmaceutical Co Ltd	308,157	$4,939,755
7	TEVA	Teva Pharmaceutical Industries Ltd	125,843	$4,263,560
8	LQDA	Liquidia Corp	43,647	$3,479,975

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,430,579	313,725	-0.6%	Shares	Sole	2026-08-13
2026-03-31	$3,922,336	315,554	-8.6%	Shares	Sole	2026-05-13
2025-12-31	$4,349,431	345,193	-12.6%	Shares	Sole	2026-02-13
2025-09-30	$3,954,850	395,090	-1.1%	Shares	Sole	2025-11-14
2025-06-30	$3,232,043	399,511	+1.5%	Shares	Sole	2025-08-14
2025-03-31	$3,297,722	393,523	-7.3%	Shares	Sole	2025-05-15
2024-12-31	$3,360,384	424,291	+3749.1%	Shares	Sole	2025-02-13
2024-09-30	$91,711	11,023	+4.4%	Shares	Sole	2024-11-13
2024-06-30	$67,017	10,554	+2.9%	Shares	Sole	2024-08-13
2024-03-31	$62,175	10,260	-0.0%	Shares	Sole	2024-05-15
2023-12-31	$62,302	10,264	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.